Sellam_2016_Arthritis.Res.Ther_18_294

Reference

Title : Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis - Sellam_2016_Arthritis.Res.Ther_18_294
Author(s) : Sellam J , Riviere E , Courties A , Rouzaire PO , Tolusso B , Vital EM , Emery P , Ferraccioli G , Soubrier M , Ly B , Hendel Chavez H , Taoufik Y , Dougados M , Mariette X
Ref : Arthritis Res Ther , 18 :294 , 2016
Abstract : Sellam_2016_Arthritis.Res.Ther_18_294
ESTHER : Sellam_2016_Arthritis.Res.Ther_18_294
PubMedSearch : Sellam_2016_Arthritis.Res.Ther_18_294
PubMedID: 27964756

Related information

Citations formats

Sellam J, Riviere E, Courties A, Rouzaire PO, Tolusso B, Vital EM, Emery P, Ferraccioli G, Soubrier M, Ly B, Hendel Chavez H, Taoufik Y, Dougados M, Mariette X (2016)
Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis
Arthritis Res Ther 18 :294

Sellam J, Riviere E, Courties A, Rouzaire PO, Tolusso B, Vital EM, Emery P, Ferraccioli G, Soubrier M, Ly B, Hendel Chavez H, Taoufik Y, Dougados M, Mariette X (2016)
Arthritis Res Ther 18 :294